All In Biotech

Drug Trial Radar · NCT07820891

A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395

A Phase 1, Open-label, Fixed-sequence Trial in Healthy Participants to Assess the Drug Interaction Potential of BGB-43395 With A Drug Cocktail Representative for CYP3A4, CYP2C9, P-gp, and BCRP Substrates

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Sep 25, 2026

Primary completion

Nov 22, 2026

Study completion Nov 22, 2026

Sponsor

Lead sponsor
BeOne MedicinesBeOne Medicines (BeiGene) (ONC)
Sponsor type
Industry
Collaborators
Fortrea
First posted
Sep 15, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will enroll healthy participants to evaluate whether BGB-43395 interacts with other drugs, including midazolam, celecoxib, dabigatran, and rosuvastatin.

Conditions

  • Healthy Adult Participants

Interventions

  • BGB-43395Drug

    Administered orally

  • MidazolamDrug

    Administered orally

  • CelecoxibDrug

    Administered orally

  • Dabigatran etexilateDrug

    Administered orally

  • RosuvastatinDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Concentration Time Curve from Time Zero to Infinity (AUC0-inf)Time frame: Samples will be collected predose and at specified timepoints, up to 10 days
  2. Area Under the Concentration Time Curve From Time Zero to the Time of the Last Quantifiable Concentration (AUC0-tlast)Time frame: Samples will be collected predose and at specified timepoints, up to 10 days
  3. Maximum Observed Concentration (Cmax)Time frame: Samples will be collected predose and at specified timepoints, up to 10 days
  4. Time to Reach Maximum Observed Concentration (Tmax)Time frame: Samples will be collected predose and at specified timepoints, up to 10 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fortrea Clinical Research Unit

    Dallas, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.